GlassScriptPhysician profile
Tara M Kirkpatrick
NPI 1518227958
$7,837.59
in general payments reported to CMS, 2019-2025
33 companies · $5,842 in 2025
The $5,842 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $226 · 2021: $359 · 2022: $350 · 2023: $273 · 2024: $267 · 2025: $5,842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,639 · Food and Beverage: $659 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,638.89 |
| Food and Beverage | $658.52 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $5,638.89 | 2025 | Nanoknife |
| Astellas Pharma US INC | $410.14 | 2019-2023 | Veozah |
| Abbvie INC. | $385.36 | 2019-2025 | |
| Boston Scientific Corporation | $169.15 | 2019-2025 | Spaceoar Vue System - 10ml |
| Neotract INC. | $137.05 | 2019-2020 | |
| Pfizer INC. | $100.82 | 2019-2024 | |
| Janssen Biotech, INC. | $96.91 | 2022-2024 | Erleada, Akeega |
| Urogen Pharma, INC. | $77.73 | 2025 | |
| Procept Biorobotics Corporation | $77.40 | 2024 | Aquabeam System |
| Myovant Sciences INC. | $76.29 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $65.12 | 2019-2022 | |
| Travere Therapeutics, INC. | $58.98 | 2019-2022 | |
| Medtronic, INC. | $54.07 | 2024 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $51.10 | 2022-2025 | |
| Allergan, INC. | $43.98 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Isoray, INC | $36.09 | 2022 | |
| Calyxo, INC. | $35.60 | 2025 | Cvac Aspiration System |
| Davol INC. | $34.37 | 2020 | |
| Novo Nordisk INC | $33.72 | 2023 | Saxenda, Wegovy |
| Axonics, INC. | $31.94 | 2021 | |
| Karl Storz Endoscopy-America | $28.02 | 2019 | |
| Sun Pharmaceutical Industries INC. | $27.60 | 2020-2022 | |
| Coloplast Corp | $23.12 | 2019-2021 | |
| Rochester Medical Corporation | $17.25 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $16.66 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.64 | 2024 | Adstiladrin |
| Foundation Medicine, INC. | $14.84 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.29 | 2025 | Lynparza |
| Blue Earth Diagnostics | $14.21 | 2020 | |
| Photocure INC | $14.01 | 2023 | Cysview |
| Endo Pharmaceuticals INC. | $13.06 | 2023 | Aveed, Xiaflex |
| Amgen INC. | $12.24 | 2021 | |
| Merck Sharp & Dohme LLC | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Kirkpatrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.